172 related articles for article (PubMed ID: 9916933)
1. CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.
Sträter J; Mariani SM; Walczak H; Rücker FG; Leithäuser F; Krammer PH; Möller P
Am J Pathol; 1999 Jan; 154(1):193-201. PubMed ID: 9916933
[TBL] [Abstract][Full Text] [Related]
2. CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies.
Sträter J; Walczak H; Hasel C; Melzner I; Leithäuser F; Möller P
Cell Death Differ; 2001 Mar; 8(3):273-8. PubMed ID: 11319610
[TBL] [Abstract][Full Text] [Related]
3. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
4. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P
Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274
[TBL] [Abstract][Full Text] [Related]
5. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
Hasel C; Rau B; Perner S; Sträter J; Möller P
Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
[TBL] [Abstract][Full Text] [Related]
7. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
[TBL] [Abstract][Full Text] [Related]
8. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
9. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of activation-induced cell death in individual human T cell clones.
Janssen O; Stocker A; Sanzenbacher R; Oberg HH; Siddiqi MA; Kabelitz D
Int Arch Allergy Immunol; 2000 Mar; 121(3):183-93. PubMed ID: 10729776
[TBL] [Abstract][Full Text] [Related]
11. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR.
Pinti M; Pedrazzi J; Benatti F; Sorrentino V; Nuzzo C; Cavazzuti V; Biswas P; Petrusca DN; Mussini C; De Rienzo B; Cossarizza A
FEBS Lett; 1999 Sep; 458(2):209-14. PubMed ID: 10481067
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
13. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
Li-Weber M; Krammer PH
Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
[TBL] [Abstract][Full Text] [Related]
14. An unexpected role for FosB in activation-induced cell death of T cells.
Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
[TBL] [Abstract][Full Text] [Related]
15. Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia.
Möller P; Walczak H; Reidl S; Sträter J; Krammer PH
Am J Pathol; 1996 Jul; 149(1):9-13. PubMed ID: 8686766
[TBL] [Abstract][Full Text] [Related]
16. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
[TBL] [Abstract][Full Text] [Related]
17. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
Stohl W; Xu D; Starling GC; Casali P; Kiener PA
Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
[TBL] [Abstract][Full Text] [Related]
18. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
19. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
